Halozyme Therapeutics Inc. buy UBS Group AG
Start price
03.06.26
/
50%
€59.58
Target price
03.06.27
-
Performance (%)
1.24%
Price
09:53
€60.32
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 1.24%. This prediction currently runs until 03.06.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Halozyme Therapeutics Inc. | 1.24% |
| iShares Core DAX® | -1,76 % |
| iShares Nasdaq 100 | 2,32 % |
| iShares Nikkei 225® | 5,02 % |
| iShares S&P 500 | 0,80 % |
Comments by UBS_Group_AG for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (HALO) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for HALO provided by MarketBeat